Sam Brusco, Associate Editor06.06.23
Teleflex’s Arrow EZ-IO (intraosseous) needle has gained U.S. Food and Drug Administration (FDA) 510(k) clearance for MR conditional labeling.
The EZ-IO needle has a diamond tip designed for fast, precise, and steady insertion. It can be used when intravenous access is difficult or impossible to obtain in emergent, urgent, or medically necessary cases. The new labeling lets clinicians continuously care for patients needing MRI scans without interrupting the established site for vascular access.
“Clinical and Medical Affairs is committed to supporting the expanded use of Teleflex medical devices in a continuous effort to improve patient care,” Michelle Fox, Teleflex’s corporate VP and chief medical officer, told the press. “Patients who require emergent or urgent MRI now have an additional vascular access option.”
“Teleflex continues to innovate on behalf of clinicians who are seeking to provide continuous care during critical situations,” added Kevin Robinson, president and general manager, Anesthesia and Emergency Medicine, Teleflex. “We are excited to have the Arrow EZ-IO Needle cleared as MR Conditional and look forward to finding new ways to deliver outstanding care solutions for patients and providers.”
The EZ-IO Needle is a critical component of Teleflex’s Arrow EZ-IO intraosseous vascular access system.
The EZ-IO needle has a diamond tip designed for fast, precise, and steady insertion. It can be used when intravenous access is difficult or impossible to obtain in emergent, urgent, or medically necessary cases. The new labeling lets clinicians continuously care for patients needing MRI scans without interrupting the established site for vascular access.
“Clinical and Medical Affairs is committed to supporting the expanded use of Teleflex medical devices in a continuous effort to improve patient care,” Michelle Fox, Teleflex’s corporate VP and chief medical officer, told the press. “Patients who require emergent or urgent MRI now have an additional vascular access option.”
“Teleflex continues to innovate on behalf of clinicians who are seeking to provide continuous care during critical situations,” added Kevin Robinson, president and general manager, Anesthesia and Emergency Medicine, Teleflex. “We are excited to have the Arrow EZ-IO Needle cleared as MR Conditional and look forward to finding new ways to deliver outstanding care solutions for patients and providers.”
The EZ-IO Needle is a critical component of Teleflex’s Arrow EZ-IO intraosseous vascular access system.